c myo-Inositol is a building block for all inositol-containing phospholipids in eukaryotes. It can be synthesized de novo from glucose-6-phosphate in the cytosol and endoplasmic reticulum. Alternatively, it can be taken up from the environment via Na ؉ -or H ؉ -linked myo-inositol transporters. While Na ؉ -coupled myo-inositol transporters are found exclusively in the plasma membrane, H ؉ -linked myo-inositol transporters are detected in intracellular organelles. In Trypanosoma brucei, the causative agent of human African sleeping sickness, myo-inositol metabolism is compartmentalized. De novo-synthesized myo-inositol is used for glycosylphosphatidylinositol production in the endoplasmic reticulum, whereas the myo-inositol taken up from the environment is used for bulk phosphatidylinositol synthesis in the Golgi complex. We now provide evidence that the Golgi complexlocalized T. brucei H ؉ -linked myo-inositol transporter (TbHMIT) is essential in bloodstream-form T. brucei. Downregulation of TbHMIT expression by RNA interference blocked phosphatidylinositol production and inhibited growth of parasites in culture. Characterization of the transporter in a heterologous expression system demonstrated a remarkable selectivity of TbHMIT for myo-inositol. It tolerates only a single modification on the inositol ring, such as the removal of a hydroxyl group or the inversion of stereochemistry at a single hydroxyl group relative to myo-inositol.
In all eukaryotes, myo-inositol is the precursor for all inositolcontaining phospholipids, including phosphatidylinositol (PI), phosphatidylinositol (poly)phosphates, inositol phosphorylceramide (IPC), and glycosylphosphatidylinositol (GPI). In mammalian cells, it is taken up from the environment via sodium/myoinositol cotransporters (SMITs) or proton-linked myo-inositol transport (T. brucei H ϩ -linked myo-inositol transporter [TbHMIT]). Human SMIT1 and SMIT2 belong to the sodium/ glucose transporter family, SGLT/SLC5, whose members in general mediate uptake of sugars and osmolytes in the gastrointestinal tract and the kidney (1). They are localized in the plasma membrane and, besides myo-inositol, also transport xylose and glucose (2, 3). In contrast, the human HMIT belongs to the sugar/polyol transport facilitator family, GLUT/SLC2A (4). While most members of this family are also located in the plasma membrane and regulate sugar homeostasis within the body, members of the family of subclass III transporters, to which HMIT belongs, are typically localized intracellularly (5, 6). Interestingly, GLUT12/ SLC2A12 and HMIT/SLC2A13 have been found to colocalize with Golgi complex markers (7,8). Although the substrate specificities of the subclass III GLUT/SLC2A transporters have been studied in model systems, their physiological roles have not been firmly established (5, 6). Notably, HMIT completely lacks sugar transport activity but instead transports myo-inositol with a K m of approximately 100 M in a Xenopus oocyte expression system (8).As an alternative to uptake, myo-inositol can...